GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DuoGenic StemCells Corp (ROCO:7607) » Definitions » Current Deferred Taxes Liabilities

DuoGenic StemCells (ROCO:7607) Current Deferred Taxes Liabilities : NT$0.00 Mil (As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is DuoGenic StemCells Current Deferred Taxes Liabilities?

Current Deferred Taxes Liabilities represent future tax liabilities, resulting from temporary differences between book (accounting) value of assets and liabilities and their tax value, or timing differences between the recognition of gains and losses in financial statements and their recognition in a tax computation. Deferred tax liabilities generally arise where tax relief is provided in advance of an accounting expense, or income is accrued but not taxed until received.

DuoGenic StemCells's current deferred tax liabilities for the quarter that ended in Jun. 2024 was NT$0.00 Mil.

DuoGenic StemCells Current Deferred Taxes Liabilities Historical Data

The historical data trend for DuoGenic StemCells's Current Deferred Taxes Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DuoGenic StemCells Current Deferred Taxes Liabilities Chart

DuoGenic StemCells Annual Data
Trend Dec21 Dec22 Dec23
Current Deferred Taxes Liabilities
- - -

DuoGenic StemCells Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Current Deferred Taxes Liabilities Get a 7-Day Free Trial - - - - -

DuoGenic StemCells Current Deferred Taxes Liabilities Related Terms

Thank you for viewing the detailed overview of DuoGenic StemCells's Current Deferred Taxes Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


DuoGenic StemCells Business Description

Industry
Comparable Companies
Traded in Other Exchanges
N/A
Address
Room R207, Innovation Incubation Center, 145, Xingda Road, South District, Taichung, TWN
DuoGenic StemCells Corp is a company having a team of passionate researchers focused on stem cell cultivation. Their products are intended for research use and can be upgraded for clinical applications. It also develops blood cell therapy programs, using the isolation and purification of blood mononuclear cells to remove granule cells that promote inflammation, and conducts clinical trials on various degenerative diseases to provide a convenient and simple new option for cell therapy.

DuoGenic StemCells Headlines

No Headlines